Americans pay the highest prices in the world for cancer drugs, but the treatments are least affordable in lower income countries.

VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. today announced that it has entered into a collaboration and license agreement with GlaxoSmithKline (GSK) for the research, development, and commercialization of novel Fc-engineered monoclonal and bi-specific antibody therapeutics which have been optimized for specific therapeutic effects. Under the terms of the agreement, Zymeworks and GSK will collaborate to further […]